International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 4 : 3127-3130
Research Article
Bacteriological profile and antibiogram of blood culture isolate in ESIC Medical College & Hospital in Jaipur, India
 ,
 ,
 ,
 ,
Received
June 21, 2026
Accepted
July 8, 2026
Published
July 12, 2026
Abstract

Introduction Bloodstream infections (BSIs), also known as septicemia or bacteremia, occur when bacteria or other microorganisms enter the bloodstream and cause an infection.

Materials: The study included blood samples of all inpatients of the tertiary care hospital in the department of microbiology during January 2023–December 2024.

Results: ICU and NICU are the leading contributor of BSI in our study. Gram positive organisms (65.8%) dominated our results. Staph.aureus was isolated from  (35%) were the most common isolates Among the total culture positive pathogenic isolates the CoNS  (18%) were reported S. epidermidis  (14.6%) a), S. haemolyticus (8 %) Escherchia coli.  (17%) , Salmonella typhi (15%) and Candida spp. (8%).were isolated 

Conclusion: ICUs are the point of generation of multidrug-resistant (MDR) bacterial strains, largely due to  frequent and inappropriate or incorrect use of broad-spectrum antibiotics that leads to development of drug-resistant strains.

Keywords
INTRODUCTION

Bloodstream infections (BSIs), also known as septicemia or bacteremia, occur when bacteria or other microorganisms enter the bloodstream and cause an infection1.  The most common bacteria genera responsible for BSIs are Klebsiella, Escherichia, and Staphylococcus.2,3 Factors contributing to BSI: Immunosupression,  excessive use of broad spectrum antibiotic can suppress the normal flora, thus allowing the emergence of resistant strains of bacteria.4

 

Diagnosis of BSIs involves blood cultures, where a sample of blood is collected and cultured to identify the presence of microorganisms.5,6 Prevention of BSIs is crucial, especially in healthcare settings.1,Timely identification and appropriate treatment of infections in other parts of the body can also prevent the spread of infection to the bloodstream.5 It's important to consult a healthcare professional for a proper diagnosis and treatment if you suspect a bloodstream infection or have any concerns about your health.

 

Continuous oversightof bloodstream infections (BSIs) etiology is an indispensable drillin healthcare settings to monitor the types of pathogens causing infections and their antibiotic resistance patterns.7,8 Scrutiny helps healthcare facilities to identify thetendencies, executesuitable infection control measures, and make informed decisions regarding antimicrobial therapy.9,10

 

MATERIALS AND METHODS

Study design

  • This was retrospective descriptive record based study.
  • Duration of study: Two year (January 2023–December 2024).
  • Place of Study: This study was conducted at Microbiology Department of ESIC Medical College, Jaipur Rajasthan.

 

Study population

The study included blood samples of all inpatients of the tertiary care hospital in the department of microbiology during January 2023–December 2024. In the study, contaminants and mixed bacterial growths were not included.

 

METHODS: 

This prospective study was conducted in the Department of Microbiology during the period from JAN. 2023 - DEC 2024. Two ml of venous blood was taken from each neonate &  five 5ml blood from adult cultured by automated BacT/Alert & BD phoenix method for rapid isolation & sensitivity test11,12.

 

Processing of samples

Blood cultures: Blood samples bottles were collected from the patients as suggested the physician and earlier the administration of any antibiotic. The details of the patients were recorded in registers. Samples from neonates and adult were processed were loaded in BACT/ALERT3D Automated System11,12. For negative samples blood culture bottle remains loaded in automated system and after 5 days sample is reported negative. For positive samples, the blood culture bottle is taken out from the system and then conventionally blood was inoculated with the sample were incubated at 37°C aerobically.

 

Laboratory identification: The growth obtained was identified by colony morphology, gram stain and standard biochemical identification tests. the BD PhoenixTM M50 AST13 system with priority given to critically important antibiotics, including NMIC/ID-421,  PMIC/ID-70, and NMIC-500  panels,  which  contain 15  antimicrobials  for GN bacteria, 11 antimicrobials for non-Streptococcus GP bacteria and 5 antimicrobials for Streptococcus, respectively. M50 AST not only provides AST (Sensitive: S/Resistant: R) results but alsoautomatically detects MIC. Updated annually according to the standard guidelines (CLSI, EUCAST)14.

 

RESULT AND DISCUSSION: 

Amongst the total samples processed, 282(32.8%) became culture positive among which gram positive bacteria were the most predominant (65.8%). Out of all the gram positive pathogens, Staph.aureus was isolated from  (35%)were the most common isolates Among the total culture positive pathogenic isolates the CoNS  (18%)were reported S. epidermidis  (14.6%) a), S. haemolyticus (8 %)aEscherchia coli.  (17%) and Salmonella typhi (15%).  cases whereas candida spp. were isolated (8%). The age group varied from 2 days told to 82-year-old patient, and both genders were taken into the study.

 

Figure 1

 

Gender wise ratio of male to female was 1.59:1 our study which matches with other similar studies. Neonates with low-birth-weight are highly prone to BSIs15.

Figure 2

 

Figure 3

 

Figure 4

 

Antibiogram:Gram-positive and Gram-negative bacteria showed very high resistance to most the antibiotics tested, and the statistical analysis clearly suggest that the drug resistance is undeniably significant and poses threat more-so to high-risk patients having blood culture positive.

 

BSIs are the most common nosocomial infections. Studies15,16 including ours revealed that ICU patients are at higher risk of nosocomial BSIs than those admitted to other types of units. The reason for high infectious incidence in ICU patient is self-explanatory. The causative agents are affected by underlying comorbidities such as chronic disease conditions, immunodeficiency, age, socioeconomic and environmental factors.

 

CONCLUSION:

Prevention is most effective cure in BSIs. Proper implementation of hospital infection control15,16, well trained staff and strictly imposing the rules of infection control in hospital, reducing footfall in ICUs and wards,proper use of PPE in infection prone areas and including hand hygiene practices in routine .Periodically, training the hospital staff to practice infection control and hand hygiene17.

 

Financial support and sponsorship: Nil.

 

Conflicts of interest: There are no conflicts of interest.

 

REFERENCE:

  1. Gupta S, Dhar A, Gohel D, Dingankar R. Bloodstream infections and its antibiogram from a tertiary care hospital of western India. Indian J Microbiol Res 2023;10(4):202-208.
  2. F Timsit E Ruppé F Barbier A Tabah M Bassetti Bloodstream infections in critically ill patients: an expert statementIntensive Care Med202046226684
  3. M Bassetti E Righi A Carnelutti Bloodstream infections in the Intensive Care UnitVirulence20167326779
  4. Apurba Shankar sastry- Essentials of medical microbiology. Jaypee the health science publisher. 2016: pp- 295.
  5. L Tian Z Sun Z Zhang Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective studyBMC Public Health20181811121
  6. I Blanco-Mavillard E Castro-Sánchez E Castro-Sánchez G Parra-García What fuels suboptimal care of peripheral intravenous catheter-related infections in hospitals? A qualitative study of decision-making among Spanish nursesAntimicrob Resist Infect Control2022111105
  7. J Cohran E Larson H Roach C Blane P Pierce Effect of intravascular surveillance and education program on rates of nosocomial bloodstream infectionsHeart Lung19962521614
  8. JR Leal DB Gregson DL Church EA Henderson T Ross KB Laupland The Validation of a Novel Surveillance System for Monitoring Bloodstream Infections in the Calgary ZoneCan J Infect Dis Med Microbiol2016201629358701155/2016/2935870
  9. ERM Sydnor TM Perl Hospital epidemiology and infection control in acute-care settingsClinMicrobiol Rev201124114173
  10. K Iskandar L Molinier S Hallit M Sartelli TC Hardcastle M Haqu Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered pictureAntimicrob Resist Infect Control202110163
  11. Junkins A, et al. Comparison of BD Phoenix™ AP Workflow with Vitek 2. J. Clin. Microbiol. 2010. 48 (5): 1929-1931. – Study was a supported grant from BD Diagnostic Systems
  12. Jungkind D, et al. Workflow evaluation of the BD Phoenix™ AP Compared to the MicroScan Walkaway overnight system for identification and susceptibility testing of bacteria. As presented at the 110th General Meeting of the American Society of Microbiology. May 2010. – Study was a supported grant from BD Diagnostic Systems.
  13. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 35th Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2025.
  14. AM Minassian R Newnham E Kalimeris P Bejon BL Atkins ICJW Bowler Use of an automated blood culture system (BD BACTECTM) for diagnosis of prosthetic joint infections: Easy and fastBMC Infect Dis2014141233.
  15. ChawdaH ,Mistry M, Parmar T, A study of microbiological profile and antibiotic susceptibility pattern of the organisms isolated from blood stream infection in patients of critical care units in tertiary care hospital in Western India. IP Int J Med Microbiol Trop Dis 2019;5(2):83-86
  16. Bhabhor U, Bhabhor H, Shingala H, Sinha M, Bacteriological study of blood stream infection (BSI) in ICU patients. Indian J Microbiol Res 2018;5(3):368-373
  17. Sarwariya M, Sadawarte K, Rukadikar A R, Prabhu T, Aerobic bacterial profile of blood stream infections and its antimicrobial sensitivity pattern in tertiary care hospital. Indian J Microbiol Res 2017;4(4):363-366
Recommended Articles
Research Article Open Access
Weighing In on Weight Loss: Real World Outcomes of Semaglutide in Indian Diabetics
2026, Volume-7, Issue 3 : 5159-5164
Research Article Open Access
Superbugs in the ICU: Unmasking Multidrug-Resistant Infections
2026, Volume-7, Issue 3 : 5165-5172
Research Article Open Access
Time in Range, Not Just HbA1c: Redefining Glycemic Control and Microvascular Risk
2025, Volume-6, Issue-5 : 2294-2299
Research Article Open Access
Effect of Metformin therapy on serum Vitamin B12 levels in patients with Type2 Diabetes Mellitus
2026, Volume-7, Issue 4 : 3121-3126
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 4
Citations
4 Views
4 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved